Having reviewed the benefits and risks, lets discuss who may be a suitable candidate for these medications
Semaglutide and liraglutide are structurally similar molecules with high selectivity for the GLP-1 receptor, though there are some pharmacologic differences between the two notably, liraglutide has a higher steady state concentration and greater receptor binding affinity than semaglutide, while semaglutide has an increased affinity for serum albumin (thereby improving resistance to degradation) and a longer half-life than liraglutide [38, 61, 62]
So its interesting to me that, in a lot of cases, the people whove been telling fat people that theyre eating themselves into an early grave are the same people who will admonish them for taking a weight loss drug when it may carry a risk , rather than a guarantee, of adverse health conditions
Patients should always consult their provider and know how to recognize and respond to low blood sugar symptoms
We won't write a prescription off a questionnaire alone